Literature DB >> 35368625

Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: CON.

Victoria Gutgarts1,2, Ilya G Glezerman1,2.   

Abstract

Entities:  

Keywords:  Abatacept; Acute Kidney Injury and ICU Nephrology; Apoptosis Regulatory Proteins; Immune System; Immune checkpoint inhibitors; Neoplasms; Programmed Cell Death 1 Receptor

Mesh：

Substances：

Year:  2020        PMID： 35368625      PMCID： PMC8809258          DOI： 10.34067/KID.0000132020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  24 in total

Review 1.  Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review.

Authors:  Rimda Wanchoo; Sabine Karam; Nupur N Uppal; Valerie S Barta; Gilbert Deray; Craig Devoe; Vincent Launay-Vacher; Kenar D Jhaveri
Journal:  Am J Nephrol       Date:  2017-01-12       Impact factor: 3.754

2.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

3.  Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

Authors:  James Larkin; Vanna Chiarion-Sileni; Rene Gonzalez; Jean Jacques Grob; C Lance Cowey; Christopher D Lao; Dirk Schadendorf; Reinhard Dummer; Michael Smylie; Piotr Rutkowski; Pier F Ferrucci; Andrew Hill; John Wagstaff; Matteo S Carlino; John B Haanen; Michele Maio; Ivan Marquez-Rodas; Grant A McArthur; Paolo A Ascierto; Georgina V Long; Margaret K Callahan; Michael A Postow; Kenneth Grossmann; Mario Sznol; Brigitte Dreno; Lars Bastholt; Arvin Yang; Linda M Rollin; Christine Horak; F Stephen Hodi; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2015-05-31       Impact factor: 91.245

4.  Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Authors:  Martin Reck; Delvys Rodríguez-Abreu; Andrew G Robinson; Rina Hui; Tibor Csőszi; Andrea Fülöp; Maya Gottfried; Nir Peled; Ali Tafreshi; Sinead Cuffe; Mary O'Brien; Suman Rao; Katsuyuki Hotta; Melanie A Leiby; Gregory M Lubiniecki; Yue Shentu; Reshma Rangwala; Julie R Brahmer
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

5.  Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients.

Authors:  Anushree C Shirali; Mark A Perazella; Scott Gettinger
Journal:  Am J Kidney Dis       Date:  2016-04-22       Impact factor: 8.860

6.  The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.

Authors:  Harish Seethapathy; Sophia Zhao; Donald F Chute; Leyre Zubiri; Yaa Oppong; Ian Strohbehn; Frank B Cortazar; David E Leaf; Meghan J Mooradian; Alexandra-Chloé Villani; Ryan J Sullivan; Kerry Reynolds; Meghan E Sise
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-31       Impact factor: 8.237

7.  Renal toxicities associated with pembrolizumab.

Authors:  Hassan Izzedine; Alexis Mathian; Stephane Champiat; Cécile Picard; Christine Mateus; Emilie Routier; Andrea Varga; David Malka; Alexandra Leary; Judith Michels; Jean-Marie Michot; Aurélien Marabelle; Olivier Lambotte; Zahir Amoura; Jean-Charles Soria; Sihem Kaaki; Nathalie Quellard; Jean-Michel Goujon; Isabelle Brocheriou
Journal:  Clin Kidney J       Date:  2018-11-09

8.  Anti-PD-1 Immunotherapy May Induce Interstitial Nephritis With Increased Tubular Epithelial Expression of PD-L1.

Authors:  Clarissa Cassol; Anjali Satoskar; Gerard Lozanski; Brad Rovin; Lee Hebert; Tibor Nadasdy; Sergey V Brodsky
Journal:  Kidney Int Rep       Date:  2019-06-20

9.  Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.

Authors:  Frank B Cortazar; Zoe A Kibbelaar; Ilya G Glezerman; Ala Abudayyeh; Omar Mamlouk; Shveta S Motwani; Naoka Murakami; Sandra M Herrmann; Sandhya Manohar; Anushree C Shirali; Abhijat Kitchlu; Shayan Shirazian; Amer Assal; Anitha Vijayan; Amanda DeMauro Renaghan; David I Ortiz-Melo; Sunil Rangarajan; A Bilal Malik; Jonathan J Hogan; Alex R Dinh; Daniel Sanghoon Shin; Kristen A Marrone; Zain Mithani; Douglas B Johnson; Afrooz Hosseini; Deekchha Uprety; Shreyak Sharma; Shruti Gupta; Kerry L Reynolds; Meghan E Sise; David E Leaf
Journal:  J Am Soc Nephrol       Date:  2020-01-02       Impact factor: 10.121

10.  Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs.

Authors:  Alyson Haslam; Vinay Prasad
Journal:  JAMA Netw Open       Date:  2019-05-03
View more
  1 in total

1.  The Role of Kidney Biopsy in Immune Checkpoint Inhibitor-Associated AKI.

Authors:  Arash Rashidi; Chintan Shah; Miroslav Sekulic
Journal:  Kidney360       Date:  2022-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.